Article
Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data.
Antimicrobial agents and chemotherapy - 1 Jul 2003
Hsueh Po-Ren, Teng Lee-Jene, Wu Tsu-Lan, Yang Dine, Huang Wen-Kuei, Shyr Jainn-Ming, Chuang Yin-Ching, Wan Jen-Hsien, Yan Jing-Jou, Lu Jang-Jih, Wu Jiunn-Jong, Ko Wen-Chien, Chang Feng-Yee, Yang Yi-Chueh, Lau Yeu-Jun, Liu Yung-Ching, Lee Chun-Ming, Leu Hsieh-Shong, Liu Cheng-Yi, Luh Kwen-Tay
Abstract excerpt
There is a high prevalence of beta-lactam- and macrolide-resistant Streptococcus pneumoniae in Taiwan. To understand the in vitro susceptibilities of recent isolates of S. pneumoniae to fluoroquinolones and telithromycin (which is not available in Taiwan), the MICs of 23 antimicrobial agents for 936 clinical isolates of S. pneumoniae isolated from different parts of Taiwan from 2000 to 2001 were determined by the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
